Committees; establishment, renewal, termination, etc.: Various advisory committees,

[Federal Register: November 8, 2004 (Volume 69, Number 215)]

[Notices]

[Page 64778]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr08no04-80]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

SUMMARY: The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed in table 1 of this document for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in table 1. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-463 (5 U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates indicated in table 1 of this document unless the Commissioner formally determines that renewal is in the public interest.

Table 1.

Name of committee

Date of expiration

Anesthetic and Life Support Drugs Advisory

May 1, 2006. Committee. Blood Products Advisory Committee............... May 13, 2006. Pulmonary-Allergy Drugs Advisory Committee...... May 30, 2006. Drug Safety and Risk Management Advisory

May 31, 2006. Committee. Science Advisory Board to the National Center June 2, 2006. for Toxicological Research. Peripheral and Central Nervous System Drugs June 4, 2006. Advisory Committee. Psychopharmacologic Drugs Advisory Committee.... June 4, 2006. Transmissible Spongiform Encephalopathies

June 9, 2006. Advisory Committee. Science Board to the Food and Drug

June 26, 2006. Administration. Allergenic Products Advisory Committee.......... July 9, 2006. Cardiovascular and Renal Drugs Advisory

August 27, 2006. Committee. Endocrinologic and Metabolic Drugs Advisory August 27, 2006. Committee. Oncologic Drugs Advisory Committee.............. September 1, 2006. Anti-Infective Drugs Advisory Committee......... October 7, 2006. Dermatologic and Ophthalmic Drugs Advisory

October 7, 2006. Committee. Cellular, Tissue, and Gene Therapies Advisory October 28, 2006. Committee (formerly Biological Response Modifiers Advisory Committee).

FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

Dated: October 29, 2004. Sheila Dearybury Walcoff, Associate Commissioner for External Relations.

[FR Doc. 04-24842 Filed 11-5-04; 8:45 am]

BILLING CODE 4160-01-S